These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 14728028)

  • 21. Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies?
    Rossi GP; Pitter G
    Ann N Y Acad Sci; 2006 Jun; 1069():34-50. PubMed ID: 16855133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.
    Ergul A
    Pharmacotherapy; 2002 Jan; 22(1):54-65. PubMed ID: 11794430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling.
    Kirchengast M; Münter K
    Proc Soc Exp Biol Med; 1999 Sep; 221(4):312-25. PubMed ID: 10460693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of endothelin-1 in myocardial failure.
    Sam F; Colucci WS
    Proc Assoc Am Physicians; 1999; 111(5):417-22. PubMed ID: 10519162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin receptor antagonists and cardiovascular diseases of aging.
    Love MP; McMurray JJ
    Drugs Aging; 2001; 18(6):425-40. PubMed ID: 11419917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease.
    Noll G; Wenzel RR; Lüscher TF
    Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):259-67. PubMed ID: 8739256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics.
    Dupuis J
    Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endothelin: From discovery to pharmacotherapeutic innovations].
    Richard V
    Presse Med; 2014; 43(7-8):742-55. PubMed ID: 24797866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin in cardiovascular control: the role of endothelin antagonists.
    Wenzel RR; Czyborra P; Lüscher T; Philipp T
    Curr Hypertens Rep; 1999; 1(1):79-87. PubMed ID: 10981046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
    Black SM; Mata-Greenwood E; Dettman RW; Ovadia B; Fitzgerald RK; Reinhartz O; Thelitz S; Steinhorn RH; Gerrets R; Hendricks-Munoz K; Ross GA; Bekker JM; Johengen MJ; Fineman JR
    Circulation; 2003 Sep; 108(13):1646-54. PubMed ID: 12963646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin receptor antagonists: clinical realities and future directions.
    Kirchengast M; Luz M
    J Cardiovasc Pharmacol; 2005 Feb; 45(2):182-91. PubMed ID: 15654268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular biology of endothelin.
    Schiffrin EL; Touyz RM
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S2-13. PubMed ID: 9883741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of ACE inhibitors and calcium antagonists: a logical approach.
    Ruschitzka FT; Noll G; Lüscher TF
    J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S5-16. PubMed ID: 9605596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of endothelins and their receptors in heart failure.
    Giannessi D; Del Ry S; Vitale RL
    Pharmacol Res; 2001 Feb; 43(2):111-26. PubMed ID: 11243712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade.
    Dashwood MR; Tsui JC
    Atherosclerosis; 2002 Feb; 160(2):297-304. PubMed ID: 11849651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelin receptor antagonists. Promising new agents in the management of cardiovascular disorders.
    Goddard J; Webb DJ
    Drugs R D; 1999 Jul; 2(1):1-12. PubMed ID: 10560541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.
    Deuchar GA; Docherty A; MacLean MR; Hicks MN
    Br J Pharmacol; 2002 Feb; 135(4):1060-8. PubMed ID: 11861335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin and pulmonary hypertension.
    Chen YF; Oparil S
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S49-53. PubMed ID: 10976782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.